Jichuan Pharmaceutical (600566.SH): Pudilan anti-inflammatory oral liquid will withdraw from the provincial medical insurance directory on January 1, 2022

author：Zhitong Finance 2021-10-26 18:32:28

According to 600566.SH the relevant notice, from January 1, 2022, all 305 varieties of non-ethnic drugs in the Self-supplementary Drugs of the Xinjiang Uygur Autonomous Region and the Xinjiang Production and Construction Corps will be transferred out of the scope of medical insurance payment.

The announcement shows that the company's wholly-owned subsidiary Jichuan Pharmaceutical Group Co., Ltd. the main variety of Pudi blue anti-inflammatory oral liquid is within the scope of medical insurance payment. Pudilan anti-inflammatory oral liquid will be withdrawn from the "Xinjiang Uygur Autonomous Region, Xinjiang Production and Construction Corps Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue" on January 1, 2022. In 2020, the sales amount of Pudilan anti-inflammatory oral liquid in Xinjiang Uygur Autonomous Region and Xinjiang Production and Construction Corps was about 38 million yuan.

Pudi

Previous: 2021.8.11 Pack up, prepare for the transition in China's big A shares must remember three iron general laws: The following is the traces of intraday operation sharing: The following is the recent operation of the stock analysis 2021.8.11 This week's transition to Wednesday

Next: The combination of killers and, in the end, became the boss of the killer world

Read on

The English academic journal STTT published an article: Dandelion, plate blue root of the puddylan anti-inflammatory oral solution, or effective for new crown pneumonia
dandelion Pudi
10-26
New study: Dandelion-plated blue root containing dandelion anti-inflammatory oral solution may be effective for COVID-19
dandelion Pudi
10-26
Prose style: Pudi Nian Folk Memory
Pudi
10-26
Jichuan Pharmaceutical: Pudilan anti-inflammatory oral liquid, a wholly-owned subsidiary, withdrew from the provincial medical insurance directory
Jichuan Pharmaceutical (600566): The main variety of Pudilan Anti-inflammatory Oral Liquid of Jichuan Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary, will withdraw from the "Basic ...
Pudi
10-26
Why do children ban puddish blue? Can pregnant women use it? 1. Pudi blue anti-inflammatory oral liquid is forbidden for children 2, can pregnant women use pudi blue? Is it safe?
Pudi
10-26
Pudilan oral liquid can only fight viruses? It turns out that it can cure so many diseases, parents must be clear about the authoritative advantages of pudilan oral liquid with few side effects: what are the precautions when taking pudilan
Pudi
10-26
Veterinary drug knowledge | Pharmacology, pharmacology, clinical research of Pudilan anti-inflammatory granules
Pudi
10-26
Jichuan Pharmaceutical Pudi blue anti-inflammatory oral liquid fell into a dilemma: it was successively "cleared" by the provincial medical insurance directory, and the ace of tens of billions of sales was uncertain
Pudi
10-26
The success of fans counterattacked, Kamata Shina, from the fan to AKB48 love bean gorgeous transformation into Kakuchi Shina's debut AKB48 handshake regular Kakuchi Shina's pride as a sister of Kakuchi Shina summed up
Pudi KB
10-26
Jichuan Pharmaceutical Pudi blue anti-inflammatory oral liquid walked off the "altar": star drugs withdrew from provincial medical insurance, can the development of daily chemical product lines become a new growth point?
star Pudi
10-26
Pharmacist Detailed Explanation - The difference between Pudi blue anti-inflammatory tablets and compound houttuynia tablets and combination drugs!
Pharmacies often encounter customers who ask pudi blue anti-inflammatory tablets and compound houttuynia tablets the same effect, their instructions are written with "detoxification and detoxification", then, for professional clerks, we...
Pudi
10-26
In the Central Plains Pudi, people call it "cabin worm", do you know what it is?
Pudi
10-26
Jichuan Pharmaceutical: At present, Pudilan anti-inflammatory oral liquid is only sold in China
Tonghua Shun (300033) Financial Research Center on January 22, some investors asked Jichuan Pharmaceutical (600566), hello board secretary, Pudilan oral liquid is now home...
Pudi
10-30